Literature DB >> 26993579

Fuel availability and fate in cardiac metabolism: A tale of two substrates.

Florencia Pascual1, Rosalind A Coleman2.   

Abstract

The heart's extraordinary metabolic flexibility allows it to adapt to normal changes in physiology in order to preserve its function. Alterations in the metabolic profile of the heart have also been attributed to pathological conditions such as ischemia and hypertrophy; however, research during the past decade has established that cardiac metabolic adaptations can precede the onset of pathologies. It is therefore critical to understand how changes in cardiac substrate availability and use trigger events that ultimately result in heart dysfunction. This review examines the mechanisms by which the heart obtains fuels from the circulation or from mobilization of intracellular stores. We next describe experimental models that exhibit either an increase in glucose use or a decrease in FA oxidation, and how these aberrant conditions affect cardiac metabolism and function. Finally, we highlight the importance of alternative, relatively under-investigated strategies for the treatment of heart failure. This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac metabolism; Fatty acid oxidation; Glucose oxidation; Hypertrophy; Substrate switching; Substrate uptake; Ventricular function

Mesh:

Substances:

Year:  2016        PMID: 26993579      PMCID: PMC4983230          DOI: 10.1016/j.bbalip.2016.03.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  157 in total

1.  Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function.

Authors:  Trisha J Grevengoed; Sarah A Martin; Lalage Katunga; Daniel E Cooper; Ethan J Anderson; Robert C Murphy; Rosalind A Coleman
Journal:  J Lipid Res       Date:  2015-07-01       Impact factor: 5.922

2.  Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.

Authors:  R S Haltiwanger; G D Holt; G W Hart
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

3.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

4.  CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness.

Authors:  Claire C Bastie; Tahar Hajri; Victor A Drover; Paul A Grimaldi; Nada A Abumrad
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

5.  Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

Authors:  M M Awan; E D Saggerson
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function.

Authors:  Yan Huang; Li Lei; Dinggang Liu; Ion Jovin; Raymond Russell; Randall S Johnson; Annarita Di Lorenzo; Frank J Giordano
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

7.  Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.

Authors:  Danilo Neglia; Alberto De Caterina; Paolo Marraccini; Andrea Natali; Marco Ciardetti; Cecilia Vecoli; Amalia Gastaldelli; Demetrio Ciociaro; Paola Pellegrini; Roberto Testa; Luca Menichetti; Antonio L'Abbate; William C Stanley; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-05       Impact factor: 4.733

8.  Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Adam L Dorfman; Sarah Longnus; Mario Pende; Kathleen A Martin; John Blenis; George Thomas; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.

Authors:  Ole Johan Kemi; Marcello Ceci; Ulrik Wisloff; Serena Grimaldi; Paolo Gallo; Godfrey L Smith; Gianluigi Condorelli; Oyvind Ellingsen
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

10.  Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.

Authors:  Sara Tucci; Ulrich Flögel; Sven Hermann; Marga Sturm; Michael Schäfers; Ute Spiekerkoetter
Journal:  Biochim Biophys Acta       Date:  2014-02-12
View more
  30 in total

1.  Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.

Authors:  Liyang Zhao; Florencia Pascual; Lawrence Bacudio; Amanda L Suchanek; Pamela A Young; Lei O Li; Sarah A Martin; Joao-Paulo Camporez; Rachel J Perry; Gerald I Shulman; Eric L Klett; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2019-04-11       Impact factor: 5.157

2.  Sex difference in cardiac metabolism in nonischemic heart failure: Insight for prognostic value of altered cardiac metabolism.

Authors:  Hyung-Jun Im; Gi Jeong Cheon
Journal:  J Nucl Cardiol       Date:  2016-04-06       Impact factor: 5.952

3.  Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy.

Authors:  Ali M Tabish; Mohammed Arif; Taejeong Song; Zaher Elbeck; Richard C Becker; Ralph Knöll; Sakthivel Sadayappan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-26       Impact factor: 4.733

4.  The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo.

Authors:  Monte S Willis; Amro Ilaiwy; Megan D Montgomery; Paul C Simpson; Brian C Jensen
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

Review 5.  Cardiovascular Metabolomics.

Authors:  Robert W McGarrah; Scott B Crown; Guo-Fang Zhang; Svati H Shah; Christopher B Newgard
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

6.  The HVCN1 voltage-gated proton channel contributes to pH regulation in canine ventricular myocytes.

Authors:  Jianyong Ma; Xiaoqian Gao; Yutian Li; Thomas E DeCoursey; Gary E Shull; Hong-Sheng Wang
Journal:  J Physiol       Date:  2022-03-18       Impact factor: 6.228

7.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25

8.  Mitochondrial autophagy and cell survival is regulated by the circadian Clock gene in cardiac myocytes during ischemic stress.

Authors:  Inna Rabinovich-Nikitin; Mina Rasouli; Cristine J Reitz; Illana Posen; Victoria Margulets; Rimpy Dhingra; Tarak N Khatua; James A Thliveris; Tami A Martino; Lorrie A Kirshenbaum
Journal:  Autophagy       Date:  2021-08-07       Impact factor: 13.391

9.  Alterations in the carnitine cycle in a mouse model of Rett syndrome.

Authors:  Sabrina Mucerino; Anna Di Salle; Nicola Alessio; Sabrina Margarucci; Raffaella Nicolai; Mariarosa A B Melone; Umberto Galderisi; Gianfranco Peluso
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

10.  Noninvasive assessment of myocardial energy metabolism and dynamics using in vivo deuterium MRS imaging.

Authors:  Tao Wang; Xiao-Hong Zhu; Huan Li; Yi Zhang; Wei Zhu; Hannes M Wiesner; Wei Chen
Journal:  Magn Reson Med       Date:  2021-07-06       Impact factor: 3.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.